carboxyamido-triazole has been researched along with bms 214662 in 1 studies
| Studies (carboxyamido-triazole) | Trials (carboxyamido-triazole) | Recent Studies (post-2010) (carboxyamido-triazole) | Studies (bms 214662) | Trials (bms 214662) | Recent Studies (post-2010) (bms 214662) |
|---|---|---|---|---|---|
| 105 | 15 | 22 | 49 | 8 | 9 |
| Protein | Taxonomy | carboxyamido-triazole (IC50) | bms 214662 (IC50) |
|---|---|---|---|
| GTPase HRas | Homo sapiens (human) | 0.0013 | |
| GTPase KRas | Homo sapiens (human) | 0.7723 | |
| Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Homo sapiens (human) | 0.3617 | |
| Protein farnesyltransferase subunit beta | Homo sapiens (human) | 0.0021 | |
| Geranylgeranyl transferase type-1 subunit beta | Homo sapiens (human) | 1.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frett, B; Kaiser, CE; Li, HY; Wang, Y | 1 |
1 review(s) available for carboxyamido-triazole and bms 214662
| Article | Year |
|---|---|
Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.
Topics: Cell Cycle Proteins; Humans; Models, Biological; Molecular Structure; Molecular Targeted Therapy; Mutation; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; ras Proteins; Signal Transduction; Small Molecule Libraries | 2013 |